Actualiteit

A research by Instituto Bernabeu investigates the regions that affect the vaginal and endometrial microbiome

  • 16-08-2018

With the incorporation of genetic techniques, it has been possible to identify a greater number of microorganisms that cannot be analysed with a normal microbiological culture and that make up the vaginal microbiome. A powerful tool to identify the microbiome are the massive sequencing techniques. The analysis of the microbiome is important since, among other things, in the field of reproductive medicine it is possible to detect if there is a microorganism that can facilitate or hinder the implantation of the embryo.

Meer lezen

Instituto Bernabeu undertakes research to discover the link between blastocyst quality, aneuploidy rates and embryo mosaicism

  • 08-08-2018

Since one of the parameters that enable us to measure assisted reproductive treatment efficiency is embryo morphology, its research is highly critical.

Meer lezen

According to a study by Instituto Bernabeu, embryo aneuploidies in chromosomal segments are more frequent in young women

  • 01-08-2018

A study performed in the molecular biology and genetics laboratory at Instituto Bernabeu, IB Biotech, and submitted to the Spanish Fertility Society (SEF) congress has concluded that there is an increased risk of embryo abnormalities in chromosomal segments in young women.

Meer lezen

According to a study performed by Instituto Bernabeu, heparin improves prognosis in patients who have suffered from recurrent pregnancy loss and implantation failure

  • 25-07-2018

Research carried out by Instituto Bernabeu has concluded that the use of heparin, an anticoagulant drug, improves prognosis in courses of in vitro fertilisation treatment (IVF) and ICSI (intracytoplasmic sperm injection) in patients who have experienced recurrent pregnancy loss or repeated implantation failure.

Meer lezen

Instituto Bernabeu discovers that there is a decreased chance of successful pregnancy in embryos with a larger mitochondrial DNA content

  • 19-07-2018

Instituto Bernabeu has submitted research work managed by Belén Lledó, Director of the clinic's Genetics Unit, to the Spanish Fertility Society (SEF) congress. The research involved analysis of mitochondrial DNA (mtDNA) in embryos and its link to the success of in vitro fertilisation treatment (IVF).

Meer lezen

A study performed by Instituto Bernabeu researches the use of drugs in patients with poor response under different conditions to those authorised for an IVF programme

  • 11-07-2018

Instituto Bernabeu has submitted research work to the 32nd Spanish Fertility Society (SEF) National Congress held in Madrid. The aim of the study is to gain an understanding of drugs under conditions that differ from authorised use for courses of in vitro fertilisation (IVF) in patients with poor response, the frequency with which they are used in these cases and a review of the legal side to their administration. The research work is entitled: ‘Use of drugs under different conditions to those authorised within the framework of a course of in vitro fertilisation: a review of legal aspects and experience of use in patients with poor ovarian response.’

Meer lezen

The Rafael Bernabeu Foundation social welfare programme consolidates its support for members of APSA so that they can use genetic diagnosis to conceive healthy children.

  • 10-07-2018

Parents' main aim in life is to ensure that their children are born healthy and that they, as parents, have the chance to ensure this happens. With this in mind, the Rafael Bernabeu Foundation makes its resources and research available so that people faced with health issues and also financial difficulties can try for children who are free of the illness they are carrying. The Rafael Bernabeu Foundation, Instituto Bernabeu's social wellness programme has, for many years, been offering preferential service when providing treatment for associations and social entities, including members of the Association in Support of the Mentally Ill of Alicante (Asociación Pro Discapacitados Psíquicos de Alicante, APSA). 

Meer lezen

An Instituto Bernabeu study proposes changes to how ovarian stimulation is handled in patients with poor ovarian response

  • 04-07-2018

‘Patients with poor ovarian response have a different distribution in the follicle-stimulating hormone (FSHR) genotype.’ This is the title of the research work that Instituto Bernabeu gynaecologist, Yasmina Ben-Aicha, presented at the Spanish Fertility Society (SEF) congress. The leading national infertility event’s scientific committee has accepted a total of 16 pieces of Instituto Bernabeu research work, 12 of which are oral presentations given by their lead authors. 

Meer lezen

The ESHRE congress scientific committee nominates two items of Instituto Bernabeu research work on ovarian stimulation for best oral presentation and best poster

  • 29-06-2018

The Instituto Bernabeu Group will once again attend the world's most significant reproductive medicine congress, both in terms of the work that is presented and in the number of specialists who attend.

Meer lezen

The precision of next-generation sequencing techniques improves chances of pregnancy

  • 28-06-2018

Scientific research carried out by Instituto Bernabeu looked into the chances of a successful pregnancy using implanted embryos with chromosome mosaicism. It is a controversial issue because these embryos have a chromosomal abnormality in some cells and, until recently, these abnormalities were not detected. Thanks to current high-precision next-generation sequencing or NGS techniques and array-CGH during pre-implantation diagnosis for detecting aneuploidies, chromosomal abnormalities can be detected with precision in chromosome segments as well as in complete chromosomes.

Meer lezen

HEEFT U RAAD NODIG?